Riskpilot← Back to searchSign inGet full accessMediMachina AB
ABActiveOrg 5591738827S:T Johannesgatan 3 EComputer programming activities · NACE 6210Est. 20180 employees
Revenue 2025
SEK 115K
0% vs 2024
EBITDA margin
17.2%
-77% vs 2024
Equity ratio
53.7%
Financial strength
Net profit 2025
SEK 5K
-87% vs 2024
| Revenue | SEK 115K | +0% |
| EBITDA | SEK 20K | -77% |
| Net profit | SEK 5K | -87% |
| Total assets | SEK 172K | +30% |
| Equity | SEK 93K | +6% |
| Employees | 0 | — |
Legal name
MediMachina AB
Org number
5591738827
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
3 oktober 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ägnar sig åt utveckling, utbildning och konsultverksamhet inom medicin, e-hälsa, mjukvara och media. T.ex. ta fram och sälja mjukvara, film, webbplatser eller tryckprodukter företrädesvis med inriktning på medicin, hälsa och e-hälsa. Även konsultverksamhet inom samma område samt som hyrläkare. Likaså föreläsningar, workshops och annan utbildning, samt framtagning av utbildningsmaterial inom nämnda områden.
Address
S:T Johannesgatan 3 E
Email
medimachina@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 4 | 9 | 115 | 115 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −0 | 2 | 88 | 20 |
| Depreciation & amort. | −0 | — | — | −22 | −11 |
| EBIT | −3 | −0 | 2 | 66 | 9 |
| Net financials | — | 0 | 1 | 1 | 0 |
| Profit before tax | −3 | −0 | 3 | 50 | 7 |
| Tax | −0 | — | — | −10 | −1 |
| Net profit | −3 | −0 | 3 | 40 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 47 | 48 | 51 | 132 | 172 |
| Equity | 45 | 45 | 48 | 87 | 93 |
| Long-term debt | 2 | 2 | 2 | 0 | — |
| Short-term debt | 0 | 1 | 1 | 28 | 61 |
| Total debt | 2 | 3 | 3 | 28 | 61 |
EBITDA margin
17.2%
This company
15.8%
Market median
+9% vs market
20212025
Equity ratio
53.7%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
5.6%
This company
18.4%
Market median
-70% vs market
20212025
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20212025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20212025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MediMachina AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Rasmus Arvidsson | Board of Directors | 0 companies |
| Eva Ingegerd Arvidsson | Deputy Board Member | 0 companies |